Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months

This study has been completed.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: September 14, 2000
Last updated: February 13, 2012
Last verified: February 2012